Aclarion (ACON) News Today $0.16 -0.01 (-5.77%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Aclarion files to sell 27.52M shares of common stock for holdersNovember 5, 2024 | markets.businessinsider.comAclarion files to sell 20M shares of common stock for holdersOctober 25, 2024 | markets.businessinsider.comAclarion to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 10, 2024 | globenewswire.comAclarion’s Nociscan Technology Enhances Understanding of Modic Changes in Back Pain PatientsSeptember 30, 2024 | msn.comAclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesSeptember 27, 2024 | globenewswire.comPRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI TechnologySeptember 13, 2024 | globenewswire.comAclarion, Inc.: Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesSeptember 12, 2024 | finanznachrichten.deAclarion Provides Corporate Update on Nociscan AI Technology MilestonesSeptember 12, 2024 | globenewswire.comAclarion, Inc.: Aclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialSeptember 10, 2024 | finanznachrichten.deAclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialSeptember 10, 2024 | globenewswire.comAclarion Added to PRISM Emerging Medical Devices IndexSeptember 6, 2024 | globenewswire.comAclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation MarketSeptember 5, 2024 | markets.businessinsider.comAclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation MarketSeptember 5, 2024 | globenewswire.comAclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New JerseyAugust 29, 2024 | globenewswire.comMicron To $140? Here Are 10 Top Analyst Forecasts For MondayAugust 28, 2024 | msn.comMaxim Group Remains a Buy on Aclarion, Inc. (ACON)August 23, 2024 | markets.businessinsider.comAclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment PlansAugust 21, 2024 | globenewswire.comAclarion to Present at August 20th Virtual Investor Summit Microcap EventAugust 15, 2024 | globenewswire.comAclarion Announces First Commercial Agreement in MichiganAugust 14, 2024 | globenewswire.comAclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UKAugust 13, 2024 | globenewswire.comAscendiant Capital Initiates Coverage of Aclarion (ACON) with Buy RecommendationJuly 31, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Aclarion, Inc. (ACON), Edwards Lifesciences (EW) and Sanofi (OtherSNYNF)July 29, 2024 | markets.businessinsider.comAclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UKJuly 9, 2024 | globenewswire.comAclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UKJune 26, 2024 | globenewswire.comAclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonJune 25, 2024 | globenewswire.comACON Stock Earnings: Aclarion Reported Results for Q1 2024May 16, 2024 | msn.comAclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainApril 25, 2024 | globenewswire.comAclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 23, 2024 | finance.yahoo.comWhy Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionApril 2, 2024 | benzinga.comAclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsMarch 4, 2024 | finance.yahoo.comAclarion Announces Closing of $3.0 Million Public OfferingFebruary 27, 2024 | globenewswire.comWhy Aclarion (ACON) Shares Are Down Over 60% TodayFebruary 26, 2024 | msn.comAclarion Announces Pricing of $3.0 Million Public OfferingFebruary 26, 2024 | globenewswire.comWhy Is Aclarion (ACON) Stock Down 19% Today?February 26, 2024 | investorplace.comWhy Is Aclarion (ACON) Stock Down 19% Today?February 26, 2024 | investorplace.comAclarion Stock (NASDAQ:ACON), Short Interest ReportFebruary 1, 2024 | benzinga.comAclarion Stock (NASDAQ:ACON) Dividends: History, Yield and DatesJanuary 30, 2024 | benzinga.comEQS-News: Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDJanuary 22, 2024 | markets.businessinsider.comAclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDJanuary 22, 2024 | markets.businessinsider.comTrading was temporarily halted for "ACON" at 09:01 AM with a stated reason of "LULD pause."January 8, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 11:01 AM with a stated reason of "LULD pause."January 5, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 10:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 10:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 09:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 07:01 PM with a stated reason of "News pending."January 4, 2024 | marketbeat.comACLARION INC. DL-,00001 (IT2.BE)January 3, 2024 | ca.finance.yahoo.comAclarion Announces Reverse Stock SplitJanuary 2, 2024 | finance.yahoo.comAclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNovember 27, 2023 | finance.yahoo.comAclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan AdoptionNovember 9, 2023 | finance.yahoo.comAclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MDNovember 6, 2023 | markets.businessinsider.com Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. ACON Media Mentions By Week ACON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACON News Sentiment▼0.300.56▲Average Medical News Sentiment ACON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACON Articles This Week▼21▲ACON Articles Average Week Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CareMax News Today Kindly MD News Today Agape ATP News Today BioNexus Gene Lab News Today Vsee Health News Today Mangoceuticals News Today NewGenIvf Group News Today IMAC News Today Aclarion News Today American Oncology Network News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACON) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
